Clinical studies of p53 in treatment and benefit of breast cancer patients

被引:27
作者
Bergh, J [1 ]
机构
[1] Univ Hosp, Dept Oncol, SE-75185 Uppsala, Sweden
关键词
D O I
10.1677/erc.0.0060051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article describes p53 as a prognostic and predictive factor, together with some information on how best to determine the p53 status. By December 1998, 13 000 articles on p53 were identified on Pub Med, the National Library of Medicine. Within one week a further 62 articles were recorded making it difficult to give the complete p53 story. This review article will focus on discussing p53 in relation to its predictive potential. So far, no firm conclusions can be made based on the articles studied. This may be, in part, because many studies have used less than optimal techniques for determination of the p53 status, together with the fact that the studies lacked power to detect a potential difference in outcome from specific therapy in relation to p53 status.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 81 条
  • [1] Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
    Aas, T
    Borresen, AL
    Geisler, S
    SmithSorensen, B
    Johnsen, H
    Varhaug, JE
    Akslen, LA
    Lonning, PE
    [J]. NATURE MEDICINE, 1996, 2 (07) : 811 - 814
  • [2] ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER
    ALLRED, DC
    CLARK, GM
    ELLEDGE, R
    FUQUA, SAW
    BROWN, RW
    CHAMNESS, GC
    OSBORNE, CK
    MCGUIRE, WL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) : 200 - 206
  • [3] PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA
    ANDERSEN, TI
    HOLM, R
    NESLAND, JM
    HEIMDAL, KR
    OTTESTAD, L
    BORRESEN, AL
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 540 - 548
  • [4] EXPRESSION OF RAS P21, P53 AND C-ERBB-2 IN ADVANCED BREAST-CANCER AND RESPONSE TO FIRST LINE HORMONAL-THERAPY
    ARCHER, SG
    ELIOPOULOS, A
    SPANDIDOS, D
    BARNES, D
    ELLIS, IO
    BLAMEY, RW
    NICHOLSON, RI
    ROBERTSON, JFR
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (05) : 1259 - 1266
  • [5] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS
    BARNES, DM
    DUBLIN, EA
    FISHER, CJ
    LEVISON, DA
    MILLIS, RR
    [J]. HUMAN PATHOLOGY, 1993, 24 (05) : 469 - 476
  • [6] Beck William T., 1997, P498
  • [7] Bergh J, 1998, RECENT RES CANCER, V152, P328
  • [8] COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY
    BERGH, J
    NORBERG, T
    SJOGREN, S
    LINDGREN, A
    HOLMBERG, L
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1029 - 1034
  • [9] Time for integration of predictive factors for selection of breast cancer patients who need postoperative radiation therapy?
    Bergh, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09): : 605 - 607
  • [10] BERGH J, 1998, 23 ESMO C ATH GREECE, P179